Amazon CEO Andy Jassy reassured shareholders that the company expects to make money on its generative AI investments.
Merck says Keytruda injection on par with approved IV version in trial
Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.